Literature DB >> 12174794

Melatonin induces changes to serum cytokines in mice infected with the Venezuelan equine encephalomyelitis virus.

Nereida Valero1, Ernesto Bonilla, Héctor Pons, Leonor Chacin-Bonilla, Florencio Añez, Luz Marina Espina, Shirley Medina-Leendertz, Jorge García Tamayo.   

Abstract

We determined the influence of melatonin (MLT) on the induction of interleukin (IL)-2, IL-1 beta, IL-4, tumour necrosis factor-alpha (TNF-alpha) and gamma interferon (IFN-gamma) on mice infected with the Venezuelan equine encephalomyelitis (VEE) virus. Levels of IFN-gamma in the MLT-treated group were significantly increased (P < 0.001) when compared with the control non-infected group from day 1 to 6 post-infection (p.i.), while in infected mice treated with 500 micrograms MLT/kg of bodyweight enhanced levels of IFN-gamma were evident from 4 to 6 days p.i. No differences were detected in the levels of IL-2 between the controls, the infected mice treated with MLT and the infected untreated group, from day 2 p.i. No changes in serum levels of IL-4 were detected. In infected mice treated with MLT, blood levels of IL-1 beta were elevated almost 10-fold from day 1 to day 6 p.i. when compared to the control, the infected and the non-infected MLT-treated mice (P < 0.001). A highly significant rise (P < 0.001) of TNF-alpha was found in infected mice treated with MLT, from day 1 to 6 p.i. when compared to the other groups. A significant rise (P < 0.001) was also evident in the infected non-MLT-treated group and a less pronounced rise in the non-infected mice treated with MLT when compared to controls. The blockade of IFN-gamma and TNF-alpha did not inhibit the protective effect of MLT but when IL-1 beta was neutralized, 100% of the infected mice died suggesting that IL-1 beta induced by MLT treatment is a target cytokine to generate an immune response against the viral infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12174794     DOI: 10.1016/s0035-9203(02)90121-5

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  10 in total

1.  Melatonin decreases nitric oxide production, inducible nitric oxide synthase expression and lipid peroxidation induced by Venezuelan encephalitis equine virus in neuroblastoma cell cultures.

Authors:  Nereida Valero; Luz Marina Espina; Jesus Mosquera
Journal:  Neurochem Res       Date:  2006-06-28       Impact factor: 3.996

2.  Immune stimulation by exogenous melatonin during experimental endotoxemia.

Authors:  Katharina Effenberger-Neidnicht; Lisa Brencher; Martina Broecker-Preuss; Tim Hamburger; Frank Petrat; Herbert de Groot
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

3.  Melatonin decreases brain apoptosis, oxidative stress, and CD200 expression and increased survival rate in mice infected by Venezuelan equine encephalitis virus.

Authors:  Milagros Montiel; Ernesto Bonilla; Nereida Valero; Jesús Mosquera; Luz M Espina; Yasmir Quiroz; Melchor Álvarez-Mon
Journal:  Antivir Chem Chemother       Date:  2016-08-08

4.  Antagonistic effect of luzindole in mice treated with melatonin during the infection with the venezuelan equine encephalomyelitis virus.

Authors:  Nereida Valero; Anaís Nery; Ernesto Bonilla; Luz Marina Espina; Leonor Chacin-Bonilla; Florencio Añez; Mery Maldonado; Eddy Meleán
Journal:  Neurochem Res       Date:  2008-07-02       Impact factor: 3.996

5.  Melatonin increases interleukin-1beta and decreases tumor necrosis factor alpha in the brain of mice infected with the Venezuelan equine encephalomyelitis virus.

Authors:  Ernesto Bonilla; Nereida Valero; Leonor Chacín-Bonilla; Héctor Pons; Yraima Larreal; Shirley Medina-Leendertz; Luz Marina Espina
Journal:  Neurochem Res       Date:  2003-05       Impact factor: 4.414

Review 6.  Beneficial actions of melatonin in the management of viral infections: a new use for this "molecular handyman"?

Authors:  Jose Antonio Boga; Ana Coto-Montes; Sergio A Rosales-Corral; Dun-Xian Tan; Russel J Reiter
Journal:  Rev Med Virol       Date:  2012-04-18       Impact factor: 6.989

Review 7.  Melatonin in Early Treatment for COVID-19: A Narrative Review of Current Evidence and Possible Efficacy.

Authors:  Kristina M Cross; Dylan M Landis; Laveena Sehgal; J Drew Payne
Journal:  Endocr Pract       Date:  2021-06-10       Impact factor: 3.443

Review 8.  Melatonin: buffering the immune system.

Authors:  Antonio Carrillo-Vico; Patricia J Lardone; Nuria Alvarez-Sánchez; Ana Rodríguez-Rodríguez; Juan M Guerrero
Journal:  Int J Mol Sci       Date:  2013-04-22       Impact factor: 5.923

Review 9.  Melatonin and viral infections.

Authors:  Ernesto Bonilla; Nereida Valero; Leonor Chacín-Bonilla; Shirley Medina-Leendertz
Journal:  J Pineal Res       Date:  2004-03       Impact factor: 13.007

Review 10.  Molecular links between endocrine, nervous and immune system during chronic stress.

Authors:  Roberto Zefferino; Sante Di Gioia; Massimo Conese
Journal:  Brain Behav       Date:  2020-12-08       Impact factor: 3.405

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.